Clinical Trials Sponsored by Revotar Biopharmaceuticals AG

Total 7 results

Revotar Biopharmaceuticals AG

Completed

Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Revotar Biopharmaceuticals AG

Completed

Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

Germany
Revotar Biopharmaceuticals AG

Completed

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

Psoriasis

Germany
Noorik Biopharmaceuticals AG

Terminated

A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19

Covid19 | Hypoxemia

Spain, Croatia
Noorik Biopharmaceuticals AG

Terminated

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Cirrhosis | Ascites | Portal Hypertension

Spain
Noorik Biopharmaceuticals AG

Recruiting

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

Liver Cirrhosis | Acute Kidney Injury | Hepatorenal Syndrome | Ascites Hepatic

India
Institut Bergonié
Roche Pharma AG; National Cancer Institute, France; Seven and Eight Biopharmaceuticals...

Recruiting

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (AGADIR)

Melanoma | Pancreatic Cancer | Non Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | Solid Tumor, Adult | Virus-associated Tumors

France

Clinical Trials Sponsored by Revotar Biopharmaceuticals AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations